First Novartis Access Treatments Delivered to Kenya

First Novartis Access Treatments delivered to Kenya

First Novartis Access Treatments delivered to Kenya

Wednesday, February 24, 2016 – 8:35am

We are pleased to announce that the first Novartis Access shipment has just been delivered to Kenya. This shipment includes medicines against cardiovascular diseases, diabetes, respiratory conditions and breast cancer. The medicines are currently stored in the MEDS warehouse (Mission for Essential Drugs and Supplies) in Nairobi. MEDS is a faith-based not-for-profit medical supply chain and capacity building organization in Kenya. This initial shipment will allow us to establish the supply chain for Novartis Access treatments to Kenya and should set the foundation for smooth deliveries in the future. MEDS has already placed a follow-up order which is expected to reach the country in the next few weeks. As responsibility for healthcare is decentralized in Kenya, the roll-out of Novartis Access will be done county by county. The targeted end price paid by patients should be equal to or lower than USD 1.50 (KES 150) per treatment per month. Through this phased approach,we aim to build a steady supply of medicines for patients that are already on Novartis Access treatments as chronic diseases require long-term treatment. To date, eight out of the 15 medicines in the Novartis Access portfolio have received marketing authorizations in Kenya.

read more

Filed in: Editors Picks Tags: , , , , ,

Related Posts

Bookmark and Promote!

Leave a Reply

Submit Comment


© 2017 Medicalkenya. All rights reserved. XHTML / CSS Valid.